Novo Nordisk

SEP 11, 2026 · PHASE 1 TRIAL

A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity

ClinicalTrials.gov

Phase 1 registry record with no results posted; describes a planned bioavailability study designed to measure food and water effects on zenagamtide absorption in an estimated 320 participants with overweight or obesity.

SEP 11, 2026 · INTERVENTIONAL STUDY

Cities for Better Health Childhood Obesity Prevention Initiative

ClinicalTrials.gov

This is a study registration for an ongoing community-based intervention trial with no results reported; enrollment is active and follow-up data collection is not yet complete.

SEP 11, 2026 · PHASE 3 TRIAL

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is actively recruiting and has not yet reported efficacy or safety outcomes.

SEP 10, 2026 · PHASE 1 TRIAL

A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet

ClinicalTrials.gov

Phase 1 interventional study with no reported results; registry record describes planned enrollment and design only, insufficient to assess efficacy or safety outcomes.

SEP 10, 2026 · PHASE 1 TRIAL

The Role of the Amylin Analogue Cagrilintide in Bone Metabolism

ClinicalTrials.gov

Phase 1 interventional trial in recruitment examining a novel agent (cagrilintide) on a surrogate bone metabolism endpoint; no results reported in this registry record.

SEP 9, 2026 · PHASE 3 TRIAL

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

ClinicalTrials.gov

This is a Phase 3 registry record with no reported results; the study is active but not recruiting, so outcomes remain unreported in this source.

SEP 9, 2026 · PHASE 1 TRIAL

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

ClinicalTrials.gov

Phase 1 safety study with no posted results; registry record describes planned conduct only, not outcomes.

SEP 9, 2026 · PHASE 3 TRIAL

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is actively recruiting and outcomes have not yet been reported.